Tandem Diabetes Care Inc (Tandem Diabetes) is an insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems for diabetes management. The company offers the Tandem Mobi system and the t:slim X2 insulin pump, which features Control-IQ advanced hybrid closed-loop technology. Its Tandem Mobi system is an automated insulin delivery system designed to help keep blood sugars in range, and the t:slim X2 insulin pump is designed for managing diabetes. The company also provides diabetes education, pump training, software updates, and pump benefit programs. It operates in Canada, Switzerland, the Netherlands, and the US. Tandem Diabetes is headquartered in San Diego, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Tandem Diabetes Care Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Tandem Diabetes Care Inc Company Overview
- Tandem Diabetes Care Inc Company Snapshot
- Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview
- Tandem Diabetes Care Inc - Pipeline Analysis Overview
- Tandem Diabetes Care Inc - Key Facts
- Tandem Diabetes Care Inc - Major Products and Services
- Tandem Diabetes Care Inc Pipeline Products by Development Stage
- Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status
- Tandem Diabetes Care Inc Pipeline Products Overview
- Control-IQ
- Product Status
- CSII Catheter
- CSII Catheter Product Overview
- CSII Catheter Clinical Trial
- Next Generation Closed Loop
- Next Generation Closed Loop Product Overview
- Next Generation Gswim
- Next Generation Gswim Product Overview
- Sigi Patch Pump
- Sigi Patch Pump Product Overview
- Sigi Patch Pump Clinical Trial
- SteadiSet Infusion Set
- SteadiSet Infusion Set Product Overview
- t:connect Mobile - Biometric Authentication
- t:connect Mobile - Biometric Authentication Product Overview
- t:connect Mobile - Decision Support
- t:connect Mobile - Decision Support Product Overview
- t:connect Mobile - Health App Integration
- t:connect Mobile - Health App Integration Product Overview
- t:slim X3 Insulin Pump
- t:slim X3 Insulin Pump Product Overview
- Tandem Mobi: Tubeless
- Tandem Mobi: Tubeless Product Overview
- Tandem Patch
- Tandem Patch Product Overview
- Tandem Diabetes Care Inc - Key Competitors
- Tandem Diabetes Care Inc - Key Employees
- Tandem Diabetes Care Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Tandem Diabetes Care Inc, Recent Developments
- May 21, 2025: Capillary Biomedical Receives 510(K) Clearance For SteadiSet Infusion Set
- Mar 19, 2025: Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes
- Mar 18, 2025: Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States
- Mar 10, 2025: Tandem Diabetes Care Receives 510(K) Clearance For Control-IQ
- Feb 26, 2025: FDA clears Tandem’s Control-IQ+ technology for type 2 diabetes
- Feb 13, 2025: Tandem Diabetes Care Announces Upcoming Conference Presentations
- Dec 10, 2024: Tandem T:Slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada
- Sep 19, 2024: Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-Rapid Acting Insulin in European Union
- Aug 08, 2024: Tandem Diabetes Care Receives Additional FDA 510(k) Clearance for Tandem Mobi Insulin Pump With Interoperable Technology
- Jul 29, 2024: Tandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health Canada
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview
- Tandem Diabetes Care Inc Pipeline Products by Equipment Type
- Tandem Diabetes Care Inc Pipeline Products by Indication
- Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status
- Tandem Diabetes Care Inc, Key Facts
- Tandem Diabetes Care Inc, Major Products and Services
- Tandem Diabetes Care Inc Number of Pipeline Products by Development Stage
- Tandem Diabetes Care Inc Pipeline Products Summary by Development Stage
- Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status
- Tandem Diabetes Care Inc Ongoing Clinical Trials Summary
- Product Status
- Control-IQ - Product Description
- CSII Catheter - Product Status
- CSII Catheter - Product Description
- CSII Catheter - A Pilot Study for the Systematic Evaluation of the Inflammatory Response to Commercially Available Insulin Infusion Catheters in Subcutaneous Adipose Tissue
- Next Generation Closed Loop - Product Status
- Next Generation Closed Loop - Product Description
- Next Generation Gswim - Product Status
- Next Generation Gswim - Product Description
- Sigi Patch Pump - Product Status
- Sigi Patch Pump - Product Description
- Sigi Patch Pump - Sigi Insulin Management System - First-in-Human Study
- SteadiSet Infusion Set - Product Status
- SteadiSet Infusion Set - Product Description
- t:connect Mobile - Biometric Authentication - Product Status
- t:connect Mobile - Biometric Authentication - Product Description
- t:connect Mobile - Decision Support - Product Status
- t:connect Mobile - Decision Support - Product Description
- t:connect Mobile - Health App Integration - Product Status
- t:connect Mobile - Health App Integration - Product Description
- t:slim X3 Insulin Pump - Product Status
- t:slim X3 Insulin Pump - Product Description
- Tandem Mobi: Tubeless - Product Status
- Tandem Mobi: Tubeless - Product Description
- Tandem Patch - Product Status
- Tandem Patch - Product Description
- Tandem Diabetes Care Inc, Key Employees
- Tandem Diabetes Care Inc, Subsidiaries
- Glossary
- Tandem Diabetes Care Inc Pipeline Products by Equipment Type
- Tandem Diabetes Care Inc Pipeline Products by Development Stage
- Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Insulet Corp
- Solara Medical Supplies, Inc.
- Medtronic MiniMed Inc
- Eli Lilly and Co
- DexCom Inc
